Use of the one-shot Johnson & Johnson COVID vaccine will resume within days, but with a warning added to its label about the risk for a rare blood-clotting disorder that has occurred among young women, the Food and Drug Administration announced.from International-News-Economic Times https://ift.tt/3tRk7Da
via IFTTT
0 comments:
Post a Comment